Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 165

    1.

    Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks.

    Wiegand TW, Rogers AH, McCabe F, Reichel E, Duker JS.

    Br J Ophthalmol. 2009 Jan;93(1):47-51. Epub 2008 Oct 29.PMID: 18971238 [PubMed - indexed for MEDLINE]Related articles

    2.

    Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.

    Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.

    Am J Ophthalmol. 2009 Oct;148(4):584-590.e2. Epub 2009 Jul 9.PMID: 19541288 [PubMed - indexed for MEDLINE]Related articles

    3.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.

    Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.

    Br J Ophthalmol. 2007 Feb;91(2):157-60. Epub 2006 Jul 26.PMID: 16870653 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.

    Br J Ophthalmol. 2009 Apr;93(4):448-51. Epub 2008 Dec 17.PMID: 19091851 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

    7.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

    Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

    Acta Ophthalmol. 2009 Jun;87(4):404-7. Epub 2008 Sep 8.PMID: 18782335 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24.PMID: 17459318 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal injection of bevacizumab for the treatment of choroidal neovascularization in a patient with angioid streaks.

    Liu YC, Yang CS, Shyong MP, Lee FL, Lee SM.

    J Chin Med Assoc. 2009 Feb;72(2):98-102.PMID: 19251540 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin).

    Neri P, Salvolini S, Mariotti C, Mercanti L, Celani S, Giovannini A.

    Br J Ophthalmol. 2009 Feb;93(2):155-8. Epub 2008 Oct 29.PMID: 18971232 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

    Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.

    Br J Ophthalmol. 2007 Feb;91(2):161-5. Epub 2006 Aug 16.PMID: 16914470 [PubMed - indexed for MEDLINE]Related articles

    14.

    Selective occlusion of subfoveal choroidal neovascularization in angioid streaks by using a new technique of ingrowth site treatment.

    Costa RA, Calucci D, Cardillo JA, Farah ME.

    Ophthalmology. 2003 Jun;110(6):1192-203.PMID: 12799247 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series.

    Donati MC, Virgili G, Bini A, Giansanti F, Rapizzi E, Giacomelli G, Menchini U.

    Ophthalmologica. 2009;223(1):24-7. Epub 2008 Oct 13.PMID: 18849633 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.

    Mandal S, Garg S, Venkatesh P, Mithal C, Vohra R, Mehrotra A.

    Arch Ophthalmol. 2007 Nov;125(11):1487-92.PMID: 17998509 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization.

    Adán A, Mateo C, Navarro R, Bitrian E, Casaroli-Marano RP.

    Retina. 2007 Nov-Dec;27(9):1180-6.PMID: 18046222 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.

    Tran TH, Fardeau C, Terrada C, Ducos De Lahitte G, Bodaghi B, Lehoang P.

    Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1685-92. Epub 2008 Aug 6.PMID: 18682970 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

    Lazic R, Gabric N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.PMID: 17111146 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data